|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.43 USD | -1.43% |
|
-9.02% | -31.33% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.17B | 2.33B | 2.41B | 2.56B | 2.73B | |||||
Total Revenues | 2.17B | 2.33B | 2.41B | 2.56B | 2.73B | |||||
Cost of Goods Sold, Total | 250M | 292M | 269M | 294M | 329M | |||||
Gross Profit | 1.92B | 2.04B | 2.15B | 2.27B | 2.4B | |||||
Selling General & Admin Expenses, Total | 708M | 798M | 872M | 975M | 1.08B | |||||
R&D Expenses | 293M | 344M | 361M | 395M | 457M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 8.5M | 11.9M | 14M | 25M | 32.5M | |||||
Other Operating Expenses, Total | 1.01B | 1.15B | 1.25B | 1.39B | 1.56B | |||||
Operating Income | 908M | 884M | 899M | 876M | 831M | |||||
Interest Expense, Total | -4.6M | -1.8M | -2.3M | -1.8M | -2M | |||||
Interest And Investment Income | 66.1M | 67.6M | 92.4M | 93.6M | 105M | |||||
Net Interest Expenses | 61.5M | 65.8M | 90.1M | 91.8M | 103M | |||||
Currency Exchange Gains (Loss) | 200K | -3.3M | -3.8M | -2.1M | -1M | |||||
EBT, Excl. Unusual Items | 969M | 947M | 985M | 966M | 933M | |||||
Gain (Loss) On Sale Of Investments | -19.6M | -18.5M | -9.8M | 6.4M | 12M | |||||
EBT, Incl. Unusual Items | 950M | 928M | 976M | 972M | 945M | |||||
Income Tax Expense | 134M | 131M | 135M | 126M | -112M | |||||
Earnings From Continuing Operations | 816M | 797M | 840M | 846M | 1.06B | |||||
Net Income to Company | 816M | 797M | 840M | 846M | 1.06B | |||||
Net Income - (IS) | 816M | 797M | 840M | 846M | 1.06B | |||||
Net Income to Common Incl Extra Items | 816M | 797M | 840M | 846M | 1.06B | |||||
Net Income to Common Excl. Extra Items | 816M | 797M | 840M | 846M | 1.06B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.13 | 6.36 | 7.19 | 7.65 | 9.85 | |||||
Basic EPS - Continuing Operations | 6.13 | 6.36 | 7.19 | 7.65 | 9.85 | |||||
Basic Weighted Average Shares Outstanding | 133M | 125M | 117M | 111M | 107M | |||||
Net EPS - Diluted | 6.08 | 6.31 | 7.1 | 7.46 | 9.62 | |||||
Diluted EPS - Continuing Operations | 6.08 | 6.31 | 7.1 | 7.46 | 9.62 | |||||
Diluted Weighted Average Shares Outstanding | 134M | 126M | 118M | 113M | 110M | |||||
Normalized Basic EPS | 4.55 | 4.73 | 5.27 | 5.46 | 5.44 | |||||
Normalized Diluted EPS | 4.52 | 4.68 | 5.2 | 5.32 | 5.31 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 930M | 909M | 932M | 935M | 892M | |||||
EBITA | 909M | 886M | 909M | 911M | 867M | |||||
EBIT | 908M | 884M | 899M | 876M | 831M | |||||
EBITDAR | 938M | 915M | 940M | 944M | 903M | |||||
Total Revenues (As Reported) | 2.17B | 2.33B | 2.41B | 2.56B | 2.73B | |||||
Effective Tax Rate - (Ratio) | 14.11 | 14.15 | 13.87 | 13 | -11.83 | |||||
Current Domestic Taxes | 131M | 118M | 141M | 120M | -113M | |||||
Current Foreign Taxes | 7.1M | 12.7M | 13.1M | 16.4M | 11.8M | |||||
Total Current Taxes | 138M | 130M | 154M | 137M | -101M | |||||
Deferred Domestic Taxes | -1.1M | -1.3M | -23M | -5.9M | -3.6M | |||||
Deferred Foreign Taxes | -2.9M | 2.3M | 4.6M | -4.6M | -7.4M | |||||
Total Deferred Taxes | -4M | 1M | -18.4M | -10.5M | -11M | |||||
Normalized Net Income | 606M | 592M | 616M | 604M | 583M | |||||
Interest on Long-Term Debt | 4.6M | 1.8M | 2.3M | 1.8M | 2M | |||||
Non-Cash Pension Expense | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 4.1M | 4.6M | 7.6M | 12.5M | 11.9M | |||||
Selling and Marketing Expenses | 598M | 675M | 747M | 863M | 947M | |||||
General and Administrative Expenses | 111M | 116M | 117M | 112M | 129M | |||||
Research And Development Expense From Footnotes | 301M | 362M | 383M | 420M | 489M | |||||
Net Rental Expense, Total | 8.1M | 6.3M | 7.7M | 9.6M | 11.7M | |||||
Imputed Operating Lease Interest Expense | - | - | - | 4.95M | 184K | |||||
Imputed Operating Lease Depreciation | - | - | - | 4.65M | 11.52M | |||||
Stock-Based Comp., COGS (Total) | 4.8M | 5.4M | 7.7M | 8.6M | 14.1M | |||||
Stock-Based Comp., R&D Exp. (Total) | 31.8M | 42M | 48.7M | 53.1M | 76.3M | |||||
Stock-Based Comp., S&M Exp. (Total) | 42.8M | 43.2M | 56.3M | 58.2M | 79.8M | |||||
Stock-Based Comp., G&A Exp. (Total) | 40.9M | 40.8M | 32.6M | 29.8M | 35.4M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 120M | 131M | 145M | 150M | 206M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















